Philip Morris International Inc.
NYSE: PM
Stock price
192.98 USD
(+Infinity%) NaN day
Financial Performance
5Y price score: 131
The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.
A score of 100 indicates that the stock did as well as the S&P 500 Index.
A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.
10Y return: 132.7%
US$ Per
Share
By default your notes are visible only to you.
142.1
52-week range
194.6
Your model inputs
Your fair value & Margin of safety
To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.
Forecast:
Valuation
Free Cash Flow Yield
3.5 %
Dividend Yield TTM
3 %
Market cap $
$ 300,771
Price / Earnings TTM
27.1
Price / Book TTM
(32.5)
PEG TTM
0.4
Earnings growth and return
LTM
5YR
10YR
Total return (price & dividends)
10.9 %
121.4 %
132.7 %
Free cash flow per share growth
(1.1) %
15.8 %
53.5 %
Earnings per share growth
60.6 %
40.7 %
64.3 %
Founded: 1,847
Employees: 83,100
Business Summary:
Latest Earnings Call Takeaways
2026 Q1 (Apr 22, 2026)
1) Strong Start to 2026
- The company reported over $10 billion in net revenues for Q1 2026, a 9% increase YoY, with 2.7% organic growth.
- Adjusted operating income (OI) grew by 10% to $4.2 billion, with a 10% increase in adjusted gross profit to $6.9 billion.
- Adjusted diluted earnings per share (EPS) rose 16% to $1.96, benefiting from a $0.18 currency tailwind.
2) International Smoke-Free Business Performance
- The international smoke-free segment delivered double-digit volume growth and mid-teens organic revenue growth, primarily driven by IQOS.
- IQOS achieved 11% adjusted in-market sales growth, with gross margins exceeding 70%, reflecting strong pricing and operational efficiencies.
- The overall smoke-free business saw 5.3% organic net revenue growth despite challenges in the U.S. market.
3) Challenges in U.S. Market
- The U.S. segment faced headwinds, including a 10% decline in ZYN shipments due to inventory normalization and increased promotional activities.
- Cigarette volumes declined at a higher rate than expected, influenced by prior year comparisons and economic pressures.
- The company anticipates a gradual improvement in U.S. performance as comparisons normalize and new product innovations are launched.
4) Operational and Product Innovations
- The company is investing in future growth with plans to launch ZYN Innovations and expand its smoke-free portfolio.
- IQOS is set to launch new products, including IQOS ILUMA, which has received FDA reauthorization as a modified risk tobacco product.
- The company is also focused on expanding its multi-category portfolio, with significant growth in VEEV and ZYN, aiming to capture more market share.
5) Guidance and Outlook
- The company reaffirms its guidance for 2026, expecting organic net revenue growth of 5% to 7% and adjusted diluted EPS growth of 7.5% to 9.5%.
- The outlook remains cautious due to macroeconomic uncertainties, but confidence is bolstered by strong Q1 performance and ongoing investments in smoke-free products.
- The transcript lacks specific details on the anticipated impact of regulatory changes on the nicotine pouch market.
Bottom line: The company's strong Q1 results highlight its robust growth in the smoke-free segment, despite challenges in the U.S. market. Continued investment in innovation and a focus on pricing power position PM well for sustained growth, making it an attractive prospect for shareholders.
Annual Reports, Presentations And IR Contacts
Go to the websitePhilip Morris International Inc. — Financial Overview, Stock Price, Market Cap
Philip Morris International Inc. is a company. Founded in 1847. As of July 20, 2026, the company's market capitalization is $300770908800 with a current stock price of $192.98.